Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Jan-24 6:39 PM View:  | Recursion Pharmaceuticals, ... (RXRX) | 16-Jan-24 | Option Exercise | 18,000 | $2.22 | $39,960.00 | 13% 136.75K to 154.75K | |
| 18-Jan-24 6:39 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Jan-24 | Planned Option Sale | 18,000 | $10.93 | $196,740.00 | (12%) 154.75K to 136.75K | |
| 19-Dec-23 7:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Dec-23 | Option Exercise | 18,000 | $2.22 | $39,960.00 | 13% 136.75K to 154.75K | |
| 19-Dec-23 7:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Dec-23 | Planned Option Sale | 18,000 | $9.60 | $172,800.00 | (12%) 154.75K to 136.75K | |
| 17-Nov-23 5:52 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-23 | Payment of Exercise | 3,603 | $7.18 | $25,869.50 | (2%) 158.35K to 154.75K | |
| 17-Nov-23 5:52 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-23 | Option Exercise | 18,000 | $2.22 | $39,960.00 | 13% 140.35K to 158.35K | |
| 17-Nov-23 5:52 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-23 | Planned Option Sale | 18,000 | $6.51 | $117,180.00 | (12%) 154.75K to 136.75K | |
| 18-Oct-23 5:34 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Oct-23 | Option Exercise | 18,000 | $2.22 | $39,960.00 | 13% 140.35K to 158.35K | |
| 18-Oct-23 5:34 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Oct-23 | Planned Option Sale | 18,000 | $6.30 | $113,400.00 | (11%) 158.35K to 140.35K | |
| 19-Sep-23 5:50 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Sep-23 | Option Exercise | 18,000 | $2.22 | $39,960.00 | 13% 140.35K to 158.35K | |
| 19-Sep-23 5:50 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Sep-23 | Planned Option Sale | 18,000 | $8.66 | $155,880.00 | (11%) 158.35K to 140.35K | |
| 17-Aug-23 6:39 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Aug-23 | Payment of Exercise | 3,603 | $9.19 | $33,111.60 | (2%) 161.95K to 158.35K | |
| 17-Aug-23 6:39 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Aug-23 | Option Exercise | 18,000 | $2.22 | $39,960.00 | 13% 143.95K to 161.95K | |
| 17-Aug-23 6:39 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Aug-23 | Planned Option Sale | 18,000 | $9.25 | $166,500.00 | (11%) 158.35K to 140.35K | |
| 27-Jul-23 6:31 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Jul-23 | Option Exercise | 20,000 | $2.22 | $44,400.00 | 14% 143.95K to 163.95K | |
| 27-Jul-23 6:31 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Jul-23 | Planned Option Sale | 20,000 | $14.41 | $288,200.00 | (12%) 163.95K to 143.95K | |
| 27-Jul-23 6:31 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Jul-23 | Option Exercise | 20,000 | $2.22 | $44,400.00 | 14% 143.95K to 163.95K | |
| 27-Jul-23 6:31 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Jul-23 | Planned Option Sale | 20,000 | $14.30 | $286,000.00 | (12%) 163.95K to 143.95K | |
| 19-Jul-23 7:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 18-Jul-23 | Option Exercise | 30,000 | $2.22 | $66,600.00 | 21% 143.95K to 173.95K | |
| 19-Jul-23 7:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 18-Jul-23 | Planned Option Sale | 30,000 | $13.74 | $412,200.00 | (17%) 173.95K to 143.95K | |
| 19-Jul-23 7:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Jul-23 | Option Exercise | 30,000 | $2.22 | $66,600.00 | 21% 143.95K to 173.95K | |
| 19-Jul-23 7:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Jul-23 | Planned Option Sale | 30,000 | $11.72 | $351,600.00 | (17%) 173.95K to 143.95K | |
| 05-Jun-23 6:29 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-Jun-23 | Sale (Planned) | 17,865 | $8.93 | $159,534.00 | (11%) 161.82K to 143.95K | |
| 05-Jun-23 6:29 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Jun-23 | Sale (Planned) | 25,000 | $8.58 | $214,500.00 | (13%) 186.82K to 161.82K | |
| 17-May-23 6:20 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-May-23 | Payment of Exercise | 2,230 | $5.60 | $12,488.00 | (1%) 187.33K to 185.1K | |
| 17-Feb-23 5:13 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Feb-23 | Sale (Planned) | 1,768 | $8.42 | $14,886.60 | (< 1%) 189.1K to 187.33K | |
| 17-Feb-23 5:13 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Feb-23 | Payment of Exercise | 746 | $8.44 | $6,296.24 | (< 1%) 197.33K to 196.59K | |
| 17-Feb-23 5:13 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Feb-23 | Option Exercise | 7,486 | $2.22 | $16,618.90 | 4% 189.85K to 197.33K | |
| 17-Feb-23 5:13 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Feb-23 | Planned Option Sale | 7,486 | $8.33 | $62,358.40 | (4%) 196.59K to 189.1K | |
| 03-Feb-23 5:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Feb-23 | Grant | 117,090 | -- | -- | 155% 75.75K to 192.84K | |
| 03-Feb-23 5:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Feb-23 | Payment of Exercise | 2,994 | $8.55 | $25,598.70 | (2%) 192.84K to 189.85K | |
| 19-Jan-23 5:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Jan-23 | Option Exercise | 5,000 | $2.22 | $11,100.00 | 6% 78.16K to 83.16K | |
| 19-Jan-23 5:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Jan-23 | Planned Option Sale | 5,000 | $9.16 | $45,780.50 | (6%) 83.16K to 78.16K | |
| 19-Jan-23 5:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Jan-23 | Sale (Planned) | 5,000 | $9.16 | $45,780.50 | (6%) 78.16K to 73.16K | |
| 19-Dec-22 5:32 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Dec-22 | Option Exercise | 5,000 | $2.22 | $11,100.00 | 6% 83.16K to 88.16K | |
| 19-Dec-22 5:32 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Dec-22 | Planned Option Sale | 5,000 | $8.85 | $44,262.50 | (6%) 88.16K to 83.16K | |
| 19-Dec-22 5:32 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Dec-22 | Sale (Planned) | 5,000 | $8.85 | $44,262.50 | (6%) 83.16K to 78.16K | |
| 17-Nov-22 6:47 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-22 | Payment of Exercise | 613 | $11.86 | $7,270.18 | (< 1%) 93.77K to 93.16K | |
| 17-Nov-22 6:47 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-22 | Option Exercise | 5,000 | $2.22 | $11,100.00 | 6% 88.77K to 93.77K | |
| 17-Nov-22 6:47 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-22 | Planned Option Sale | 5,000 | $12.31 | $61,561.40 | (5%) 93.16K to 88.16K | |
| 17-Nov-22 6:47 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-22 | Sale (Planned) | 5,000 | $12.31 | $61,561.40 | (6%) 88.16K to 83.16K | |
| 18-Oct-22 5:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Oct-22 | Option Exercise | 5,000 | $2.22 | $11,100.00 | 5% 93.77K to 98.77K | |
| 18-Oct-22 5:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Oct-22 | Planned Option Sale | 5,000 | $10.92 | $54,589.80 | (5%) 98.77K to 93.77K | |
| 18-Oct-22 5:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Oct-22 | Sale (Planned) | 5,000 | $10.92 | $54,589.80 | (5%) 93.77K to 88.77K | |
| 16-Sep-22 6:58 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Sep-22 | Option Exercise | 5,000 | $2.22 | $11,100.00 | 5% 98.77K to 103.77K | |
| 16-Sep-22 6:58 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Sep-22 | Planned Option Sale | 5,000 | $13.36 | $66,817.40 | (5%) 103.77K to 98.77K | |
| 16-Sep-22 6:58 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Sep-22 | Sale (Planned) | 5,000 | $13.36 | $66,817.40 | (5%) 98.77K to 93.77K | |
| 17-Aug-22 6:35 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Aug-22 | Option Exercise | 25,000 | $2.22 | $55,500.00 | 24% 103.77K to 128.77K | |
| 17-Aug-22 6:35 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Aug-22 | Planned Option Sale | 25,000 | $12.61 | $315,370.00 | (19%) 128.77K to 103.77K | |
| 17-Aug-22 6:35 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Aug-22 | Sale (Planned) | 5,000 | $12.61 | $63,074.00 | (5%) 103.77K to 98.77K |